ClariVest Asset Management’s Sage Therapeutics SAGE Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-14,078	Closed	-$662K	–	835
2023 Q2	$662K	Sell	14,078 -2,797	-17%	-$139K	0.03%	316
2023 Q1	$708K	Sell	16,875 -16	-0.1%	-$688	0.03%	332
2022 Q4	$644K	Sell	16,891 -65	-0.4%	-$2.48K	0.03%	351
2022 Q3	$664K	Sell	16,956 -5,344	-24%	-$207K	0.03%	319
2022 Q2	$720K	Sell	22,300 -5,800	-21%	-$194K	0.03%	328
2022 Q1	$930K	Hold	28,100	–	–	0.04%	293
2021 Q4	$1.2M	Sell	28,100 -2,800	-9%	-$117K	0.04%	295
2021 Q3	$1.37M	Sell	30,900 -1,600	-5%	-$73.4K	0.04%	276
2021 Q2	$1.85M	Buy	+32,500	New	+$2.3M	0.06%	221
2018 Q2	–	Sell	-5,240	Closed	-$845K	–	770
2018 Q1	$845K	Buy	5,240 +100	+2%	+$17K	0.01%	448
2017 Q4	$846K	Buy	+5,140	New	+$498K	0.01%	439